These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 28901315

  • 1. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
    Guo S, Yang B, Liu H, Li Y, Li S, Ma L, Liu J, Guo W.
    J Cancer Res Ther; 2017; 13(4):689-692. PubMed ID: 28901315
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
    Guo Q, Zhu J, Wu Y, Wen H, Xia L, Wu X, Ju X.
    Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH, Yu M, Jeong S, Lee JH.
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D, Wang D, Wang S, Tian Y, Long Z, Ren X.
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [Abstract] [Full Text] [Related]

  • 10. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 11. Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients.
    Porika M, Vemunoori AK, Tippani R, Mohammad A, Bollam SR, Abbagani S.
    Asian Pac J Cancer Prev; 2010 Feb; 11(6):1745-7. PubMed ID: 21338226
    [Abstract] [Full Text] [Related]

  • 12. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ.
    Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
    [Abstract] [Full Text] [Related]

  • 13. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
    Huang SF, Wei FC, Liao CT, Wang HM, Lin CY, Lo S, Huang JJ, Chen IH, Kang CJ, Chien HT, Chen HH.
    Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
    [Abstract] [Full Text] [Related]

  • 14. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
    Pan L, Cheng J, Zhou M, Yao Z, Zhang Y.
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E, Ławicki S.
    BMC Cancer; 2019 Apr 29; 19(1):398. PubMed ID: 31035945
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG.
    J Clin Oncol; 1996 Jan 29; 14(1):111-8. PubMed ID: 8558185
    [Abstract] [Full Text] [Related]

  • 17. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I, Nakayama H, Kitamura T, Okamoto N, Inoue T.
    Int J Gynecol Cancer; 2005 Jan 29; 15(4):630-8. PubMed ID: 16014117
    [Abstract] [Full Text] [Related]

  • 18. Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.
    Chen IH, Liao CT, Wang HM, Huang JJ, Kang CJ, Huang SF.
    PLoS One; 2014 Jan 29; 9(7):e103265. PubMed ID: 25061977
    [Abstract] [Full Text] [Related]

  • 19. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.
    PLoS One; 2015 Jan 29; 10(4):e0122361. PubMed ID: 25860888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.